How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Jack Clark, Anthropic’s co-founder, left on paternity leave last November. When he returned in February, he was surprised to ...

The 10-day event drew 907 participants from 30 states and overseas, according to the Florida Fish and Wildlife Conservation Commission. The longest snake pulled during the challenge measured nearly 17 ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

We tested the best Mac antivirus software for 2026. See which apps offer the strongest protection, best performance and real value. It wasn’t long ago that Macs were considered secure enough on their ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...